AVIR
Price
$2.87
Change
+$0.02 (+0.70%)
Updated
Apr 24 closing price
Capitalization
245.46M
12 days until earnings call
IMNM
Price
$8.52
Change
+$0.02 (+0.24%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
740.82M
13 days until earnings call
Ad is loading...

AVIR vs IMNM

Header iconAVIR vs IMNM Comparison
Open Charts AVIR vs IMNMBanner chart's image
Atea Pharmaceuticals
Price$2.87
Change+$0.02 (+0.70%)
Volume$580.39K
Capitalization245.46M
Immunome
Price$8.52
Change+$0.02 (+0.24%)
Volume$35.65K
Capitalization740.82M
AVIR vs IMNM Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. IMNM commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and IMNM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AVIR: $2.87 vs. IMNM: $8.52)
Brand notoriety: AVIR and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 172% vs. IMNM: 115%
Market capitalization -- AVIR: $245.46M vs. IMNM: $740.82M
AVIR [@Biotechnology] is valued at $245.46M. IMNM’s [@Biotechnology] market capitalization is $740.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 6 bullish TA indicator(s).

  • AVIR’s TA Score: 5 bullish, 5 bearish.
  • IMNM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а -3.37% price change this week, while IMNM (@Biotechnology) price change was +7.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

AVIR is expected to report earnings on Aug 06, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($741M) has a higher market cap than AVIR($245M). AVIR YTD gains are higher at: -14.328 vs. IMNM (-19.774). IMNM has higher annual earnings (EBITDA): -109.95M vs. AVIR (-192.53M). AVIR has more cash in the bank: 455M vs. IMNM (240M). AVIR has less debt than IMNM: AVIR (1.64M) vs IMNM (2.72M). IMNM has higher revenues than AVIR: IMNM (10.1M) vs AVIR (0).
AVIRIMNMAVIR / IMNM
Capitalization245M741M33%
EBITDA-192.53M-109.95M175%
Gain YTD-14.328-19.77472%
P/E RatioN/AN/A-
Revenue010.1M-
Total Cash455M240M190%
Total Debt1.64M2.72M60%
FUNDAMENTALS RATINGS
AVIR: Fundamental Ratings
AVIR
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
76
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVIRIMNM
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LCEAX17.06N/A
N/A
Invesco Diversified Dividend A
RYTIX177.29N/A
N/A
Rydex Technology Inv
LEISX20.81N/A
N/A
Federated Hermes Equity Income IS
WFEFX13.68N/A
N/A
Allspring International Equity C
JIJAX13.11N/A
N/A
JHancock International Dynamic Gr A

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+0.24%
KYMR - IMNM
55%
Loosely correlated
+9.32%
IDYA - IMNM
54%
Loosely correlated
+1.33%
BEAM - IMNM
53%
Loosely correlated
+1.51%
RXRX - IMNM
52%
Loosely correlated
+3.05%
CCCC - IMNM
50%
Loosely correlated
N/A
More